The Treatment Based on Ruxolitinib and Amphotericin B is Effective for Relapsed Leishmaniasis-Related Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
Tingting Cui, Jingshi Wang, Zhao Wang Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People’s Republic of ChinaCorrespondence: Zhao Wang, Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People’s...
Main Authors: | Cui T, Wang J, Wang Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/the-treatment-based-on-ruxolitinib-and-amphotericin-b-is-effective-for-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis in an endemic area in the north of Minas Gerais, Brazil
by: Fernando Henrique Guimarães de Carvalho, et al.
Published: (2020-06-01) -
Unusual occurrence of hemophagocytic lymphohistiocytosis in HIV-positive person with visceral leishmaniasis
by: Ikbel Kooli, et al.
Published: (2021-12-01) -
Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review
by: Kang He, et al.
Published: (2022-10-01) -
Fatal hemophagocytic lymphohistiocytosis due to visceral leishmaniasis in a patient with Wegener granulomatosis
by: Carlo Bova, et al.
Published: (2022-01-01) -
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
by: Camille Keenan, et al.
Published: (2021-02-01)